Search Results
You are looking at 1 - 10 of 16 items for
- Author: C. G. FINK x
- Refine by access: All content x
Search for other papers by A. J.-M. C. PICKERING in
Google Scholar
PubMed
Search for other papers by G. FINK in
Google Scholar
PubMed
The mechanism of the priming effect of luteinizing hormone releasing factor (LH-RF) upon gonadotrophin secretion was studied using short-term incubation of hemipituitary glands from pro-oestrous rats. The dependence of the priming, but not the LH releasing action of LH-RF on protein synthesis in pituitary tissue was confirmed. Cytochalasin B failed to affect the first response to LH-RF, but abolished the priming effect, suggesting that the integrity of cellular microfilaments was essential. Colchicine and vinblastine did not modify the response to LH-RF. Neither inhibitors of DNA nor the inhibitor of RNA polymerase II, α-amanitin, significantly affected the priming action of LH-RF. Normal extracellular concentrations of Ca2+ were necessary for gonadotrophin release, but the priming effect was not significantly affected by low extracellular Ca2+ and could not be elicited by raising intracellular Ca2+ concentrations. Adenosine 3′:5′-cyclic phosphate did not appear to act as a second messenger for either the gonadotrophin releasing or the priming action of LH-RF.
Search for other papers by A. J.-M. C. PICKERING in
Google Scholar
PubMed
Search for other papers by G. FINK in
Google Scholar
PubMed
Extracts of hypothalamic tissue were applied to pituitary tissue in vitro to see whether they could exert a priming effect on gonadotrophin, adrenocorticotrophin, thyrotrophin or prolactin secretion. A clear-cut priming effect was seen only for gonadotrophin secretion.
Search for other papers by A. J. M. C. PICKERING in
Google Scholar
PubMed
Search for other papers by G. FINK in
Google Scholar
PubMed
Pituitary incubation studies were carried out which showed that in the rat luteinizing hormone releasing factor (LH-RF) can exert a priming effect on FSH secretion in vitro. It was found that, as for LH, the effect depends on protein synthesis. The priming effect of LH-RF with respect to FSH could also be demonstrated in vivo; however, the effect was less dramatic than for LH.
Search for other papers by A. J.-M. C. PICKERING in
Google Scholar
PubMed
Search for other papers by G. FINK in
Google Scholar
PubMed
SUMMARY
The size of the 'readily releasable pool' of luteinizing hormone at various times of the oestrous cycle has been determined by injecting a supramaximal dose of luteinizing hormone releasing factor (LH-RF) i.v. into rats anaesthetized with sodium pentobarbitone. In an attempt to block replenishment of the 'pool' during release, cycloheximide was administered 30 min before LH-RF. A 20-fold increase in pool size occurred between the morning of dioestrus and the evening of pro-oestrus in the absence of any significant change in total pituitary content of LH. This suggests that increased responsiveness may be brought about by a change in the receptor-release apparatus and/or a transfer of LH from a 'storage pool' which leads to an apparent increase in the proportion of LH available for release.
Search for other papers by A. J. M. C. PICKERING in
Google Scholar
PubMed
Search for other papers by G. FINK in
Google Scholar
PubMed
SUMMARY
The aim of this study was to determine whether the priming effect of LH-RF depends upon RNA and protein synthesis. In in-vivo studies saline, actinomycin D, or cycloheximide was administered i.p. 3·5–4 h before the first i.v. injection of synthetic LH-RF into pro-oestrous rats anaesthetized with sodium pentobarbitone at 13.30 h. The LH-response to the second injection of LH-RF (given 60 min after the first) was markedly reduced by the inhibitors, but the response to the first injection was not significantly affected. Studies with cycloheximide given i.v. showed that the inhibition of protein synthesis up to the second injection of LH-RF reduced the magnitude of the priming effect, the reduction being greatest when the inhibitor was administered up to 30 min after the first LH-RF injection. Pituitary incubation studies showed that the priming effect could also be elicited in vitro and that it could be significantly reduced by actinomycin D, cycloheximide and puromycin. As in vivo, the inhibitors had relatively little effect on the LH-response to the first exposure to LH-RF. The protein synthesized after an injection of LH-RF may be new LH, and/or a protein(s) concerned with 'activation' of the receptor or release components of the LH-secretory apparatus.
Search for other papers by R C Dow in
Google Scholar
PubMed
Search for other papers by J Bennie in
Google Scholar
PubMed
Search for other papers by G Fink in
Google Scholar
PubMed
ABSTRACT
Pituitary adenylate cyclase activating polypeptide (PACAP) was first isolated from ovine hypothalamus as two molecular forms, the basic 38 residue amidated peptide PACAP-38 and the N-terminal 27 amino acid sequence PACAP-27. A dense plexus of PACAP immunoreactive fibres is present in the internal and external layers of the median eminence and in other parts of the hypothalamus with PACAP cell bodies in the paraventricular and supraoptic nuclei. The present study shows, for the first time, that, as assessed by radioimmunoassay of extracted plasma, the amount of PACAP-38 in hypophysial portal is significantly greater than in peripheral blood, and that as assessed by reversed phase high performance liquid chromatography, PACAP 1-38 is the major form in portal blood. This evidence is crucial for the fact that PACAP-38 may be a hypothalamic-pituitary regulatory factor.
Search for other papers by T. A. MABIN in
Google Scholar
PubMed
Search for other papers by C. G. FINK in
Google Scholar
PubMed
Search for other papers by G. H. THOMAS in
Google Scholar
PubMed
In order to obtain information on the biochemical viability of oestrogen-dependent tissues in culture, studies have been carried out on the interconversion of oestrone and oestradiol by rabbit uterus in culture and the fate of the hormones in the cultured tissue (Russell & Thomas, 1973a, b). These studies are now being extended to human tissue. Significant conversion of oestrone to oestradiol has been found in human breast tumours maintained in organ culture (Wilcox & Thomas, 1972). A similar approach has been used in the present study to investigate oestrogen metabolism in tissues of the female reproductive tract during culture.
[6, 7-3H]Oestrone (30 Ci/mmol) and [6, 7-3H]oestradiol-17β (36 Ci/mmol) (Radiochemical Centre, Amersham) were checked routinely by chromatography. Stock solutions were prepared in ethanol such that 5 μl dispensed into the culture medium (5 ml) gave a final concentration of 10−9 mol/l. In experiments using 10
Search for other papers by C. E. Lewis in
Google Scholar
PubMed
Search for other papers by J. F. Morris in
Google Scholar
PubMed
Search for other papers by G. Fink in
Google Scholar
PubMed
ABSTRACT
We have investigated the possibility that microfilaments are involved in the priming effect of LH-releasing hormone (LHRH) by ultrastructural morphometry of hemipituitary glands from adult female mice. Glands incubated for 2 consecutive hours with 8·5 nmol LHRH/1 responded with a marked increase in the amount of LH released into the medium during the second hour compared with the first hour of incubation. This priming effect of LHRH on LH secretion was accompanied by a significant margination of secretory granules and a drop in the total granule content of the gonadotrophs. Although the number of microfilaments remained the same, there was an increase in their length and a change in orientation so that the angle between the microfilaments and the plasmalemma was significantly reduced after both the first and second hour of exposure of LHRH. The addition of 14·3 μmol cytochalasin B/l to the incubation medium significantly increased the amount of LH released in the first hour of incubation when compared with the amount of LH released by LHRH alone, but completely abolished the priming effect of LHRH. Cytochalasin B also prevented the LHRH-induced increase in the length and the change in orientation of the microfilaments. These results indicate that LHRH priming involves an increase in length of microfilaments and a change in their orientation relative to the plasmalemma.
J. Endocr. (1985) 106, 211–218
Search for other papers by C. E. Lewis in
Google Scholar
PubMed
Search for other papers by J. F. Morris in
Google Scholar
PubMed
Search for other papers by G. Fink in
Google Scholar
PubMed
Search for other papers by M. Johnson in
Google Scholar
PubMed
ABSTRACT
Changes in the size and position of secretory granules in pituitary gonadotrophs have been studied in relationship to LH release and self-priming induced by LH-releasing hormone (LHRH) in pituitary glands from normal and hypogonadal (hpg) female mice. Hemipituitary glands were preincubated and then incubated for either 1 or 2 h in the absence or presence of LHRH (8·5 nmol/l). The glands were either processed for ultrastructural morphometry or homogenized for the determination of pituitary LH content. Morphometry was carried out on gonadotrophs identified by immunocytochemistry for LHβ using the thin/semi-thin section method. Pituitary LH content and the amount of LH released were determined by radioimmunoassay.
The amount of LH released in response to the first and second hours of incubation with LHRH were similar in hpg and normal mice with a clear priming effect (three- to fourfold increase in pituitary responsiveness to LHRH) occurring in both strains. Despite a substantially reduced total number of granules (and amount of LH) in unstimulated hpg gonadotrophs, the number of granules in the outer 500 nm marginal zone of the cells was similar to that in normal mice. This could explain the similar amount of LH released from normal and hpg glands by the first LHRH challenge. The initial exposure to LHRH was also associated with a marked translocation of secretory granules from the central to the outer marginal region of cytoplasm subjacent to the gonadotroph plasmalemma, such that in 'primed' glands 60% of granules were found in this marginal zone compared with 40% (hpg) or 33% (normal) in unstimulated glands. The mean diameter of granules in the marginal zone was significantly less than that of granules in the central zone of the gonadotrophs of unstimulated glands from both normal and hpg animals. Exposure to LHRH for 1 h was associated with an increase in the number of small granules in the marginal zone and a significant decrease in the mean diameter of the gonadotroph granule population as a whole.
After the primed release of LH, increased proportions of granules were still located in the marginal zone of gonadotrophs, indicating that granule migration continued during the second hour of exposure to LHRH in which primed release occurred. The primed release was associated with a detectable reduction in both the LH and granule content of gonadotrophs in normal, but not hpg glands. The ultrastructural correlates of LH release and LHRH priming were similar in the two strains of mice, and therefore in mice neither the releasing nor the priming effect of LHRH depends upon previous exposure of the pituitary gland to LHRH or ovarian factors. The priming effect was associated with a marked shift of granules towards the plasmalemma and a decrease in granule size which most likely resulted from increased post-translational processing within secretory granules.
J. Endocr. (1986) 109, 35–44
Search for other papers by A. M. Horn in
Google Scholar
PubMed
Search for other papers by I. C. A. F. Robinson in
Google Scholar
PubMed
Search for other papers by G. Fink in
Google Scholar
PubMed
ABSTRACT
Oxytocin (OT) and vasopressin (VP) were measured by radioimmunoassay in hypophysial portal and peripheral blood from male Wistar rats and heterozygous and homozygous Brattleboro rats anaesthetized with urethane. In Wistar rats the concentrations of OT and VP were about 50 times greater than the concentrations in peripheral blood, whether or not the pituitary gland was left in situ during collection, and also considerably greater than the reported concentrations of the peptides in the cerebrospinal fluid. The release of both peptides was increased significantly by a lesion of the supraoptico-hypophysial tract that led to diabetes insipidus, but which left intact the external layer of the median eminence (ME). Concentrations of VP were undetectable in plasma from homozygous Brattleboro rats, but the portal plasma concentrations of VP in heterozygous Brattleboro rats were not significantly lower than in Wistar rats. The concentrations of OT in portal plasma from both types of Brattleboro rat were significantly higher than in Wistar rats.
The output of VP and OT into hypophysial portal blood of Wistar rats was not significantly affected by electrical stimulation of the suprachiasmatic, supraoptic or paraventricular nuclei or the ME using two types of stimuli, one of which produced an increase in peripheral plasma concentrations of VP and OT in intact rats and a significant increase in the release of LH-releasing hormone into hypophysial portal blood. The output of VP and OT into portal blood was also not significantly affected by either adrenalectomy with or without injection of dexamethasone or the injection of either the 5-hydroxytryptamine (5-HT) synthesis blocker, parachlorophenylalanine, or the 5-HT uptake blockers, alaproclate or zimelidine.
These results show that large amounts of OT as well as VP are released into hypophysial portal blood from fibres of the hypothalamo-neurohypophysial system that terminate in the external layer of the ME. Although distinct from the fibres that terminate in the pars nervosa (PN), the findings in Brattleboro rats show that the VP fibres of the ME system originate in neurones with a genomic mechanism for VP synthesis similar to that of the VP neurones that project to the PN. The lack of effect of adrenalectomy and the administration of 5-HT synthesis and uptake blockers must be interpreted with caution since the results obtained with electrical stimulation suggest that when the pituitary stalk is cut the release of OT and VP into portal blood approaches a maximum and may therefore be difficult to alter by experimental manipulation. The concentrations of OT and VP in portal blood are sufficiently high for these peptides to play a significant role in neural control of the anterior pituitary gland.
J. Endocr. (1985) 104, 211–224
